Biotech News

EPAM Announces Date for Fourth Quarter and Full Year 2017 Earnings Release and Conference Call

EPAM Systems (EPAM)EPAM SystemsEarnings

EPAM Systems, Inc. (NYSE:EPAM) will host a conference call at 8:00 a.m. EST on Friday, February 16, 2018 to discuss its fourth quarter and full year 2017 financial results. A news release containing these results will be issued before the call.

Investors and other interested parties can access the call in the following ways:

The live conference call will be available by dialing +1 (877) 407-0784 or +1(201) 689-8560 (outside of the U.S.). A webcast of the conference call can be accessed on the Investor Relations section of the Company's website at http://investors.epam.com .

A replay will be available approximately one hour after the call on http://investors.epam.com or by dialing +1(844) 512-2921 or +1(412) 317-6671 (outside of the U.S.) and entering the conference ID 13674698. The replay will be available until March 2, 2018.

About EPAM Systems Since 1993, EPAM Systems, Inc. (NYSE:EPAM), has leveraged its core engineering expertise to become a leading global product development and digital platform engineering services company. Through its ‘Engineering DNA’ and innovative strategy, consulting, and design capabilities, EPAM works in collaboration with its customers to deliver innovative solutions that turn complex business challenges into real business opportunities. EPAM’s global teams serve customers in over 25 countries across North America, Europe, Asia and Australia. EPAM is a recognized market leader among independent research agencies and was ranked #12 in FORBES 25 Fastest Growing Public Tech Companies , as a top information technology services company on FORTUNE’S 100 Fastest Growing Companies , and as a top UK Digital Design & Build Agency . Learn more at http://www.epam.com/ and follow us on Twitter @EPAMSYSTEMS and LinkedIn .

Contact: David Straube EPAM Systems P: +1 (267) 759-9000 x59419 david_straube@epam.com

Related news

EPAM Systems

EPAM Systems is a digital engineering and consulting company that supports software development, cloud transformation, and product engineering across industries including life sciences. It is a technology services company rather than a healthcare or biotech operator.

Recent company news

Stock data

Close
111.26 USD
Market cap
5.39B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States